Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Regulatory implications of ctDNA in immuno-oncology for solid tumors
Paz J. Vellanki, Soma Ghosh, Anand Pathak, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 2, pp. e005344-e005344
Open Access | Times Cited: 24

Showing 24 citing articles:

Recommendations for the Equitable and Widespread Implementation of Liquid Biopsy for Cancer Care
Phillip G. Febbo, Mina Alsaraf Allo, Emma B. Alme, et al.
JCO Precision Oncology (2024), Iss. 8
Open Access | Times Cited: 17
Liquid Biopsy Response Evaluation Criteria in Solid Tumors (LB-RECIST)
Mohamed A. Gouda, Filip Janků, Adam Wahida, et al.
Annals of Oncology (2023) Vol. 35, Iss. 3, pp. 267-275
Open Access | Times Cited: 29
Extracellular vesicle-based liquid biopsy biomarkers and their application in precision immuno-oncology
Karama Asleh, Valerie Dery, Cathy Taylor, et al.
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 20
Society for Immunotherapy of Cancer (SITC) recommendations on intratumoral immunotherapy clinical trials (IICT): from premalignant to metastatic disease
Jason J. Luke, Diwakar Davar, Robert H.I. Andtbacka, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 4, pp. e008378-e008378
Open Access | Times Cited: 6
Longitudinal genomic profiling using liquid biopsies in metastatic nonsquamous NSCLC following first line immunotherapy
Haolun Ding, Min Yuan, Yaning Yang, et al.
npj Precision Oncology (2025) Vol. 9, Iss. 1
Open Access
Analytical Validation of the Labcorp Plasma Complete Test, a Cell-free DNA Comprehensive Genomic Profiling Tool for Precision Oncology
Ellen L. Verner, Jennifer Jackson, Cynthia Maddox, et al.
Journal of Molecular Diagnostics (2025)
Open Access
Liver Metastases and Immune Checkpoint Inhibitor Efficacy in Patients With Refractory Metastatic Colorectal Cancer
Eric X. Chen, Jonathan M. Loree, Emma Titmuss, et al.
JAMA Network Open (2023) Vol. 6, Iss. 12, pp. e2346094-e2346094
Open Access | Times Cited: 15
Realizing the promise of Project Optimus: Challenges and emerging opportunities for dose optimization in oncology drug development
Wei Gao, Jiang Liu, Blerta Shtylla, et al.
CPT Pharmacometrics & Systems Pharmacology (2023) Vol. 13, Iss. 5, pp. 691-709
Open Access | Times Cited: 12
Liquid biopsy for gastric cancer: Techniques, applications, and future directions
Cristina Díaz del Arco, María Jesús Fernández‐Aceñero, Luís Ortega
World Journal of Gastroenterology (2024) Vol. 30, Iss. 12, pp. 1680-1705
Open Access | Times Cited: 3
Integrated analysis of circulating cell free nucleic acids for cancer genotyping and immune phenotyping of tumor microenvironment
Muskan Chaddha, Hemlata Rai, Ritu Gupta, et al.
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 6
Incorporating lesion-to-lesion heterogeneity into early oncology decision making
Rukmini Kumar, Timothy Qi, Yanguang Cao, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6
Bespoke ctDNA for longitudinal detection of molecular residual disease in high-risk melanoma patients
Sofia Genta, Daniel Vilarim Araújo, Katrina Hueniken, et al.
ESMO Open (2024) Vol. 9, Iss. 11, pp. 103978-103978
Open Access | Times Cited: 1
Liquid biopsies, are we ready for prime time?
Nicola Normanno, Kathi Apostolidis, Mark Stewart
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 2, pp. e006302-e006302
Open Access | Times Cited: 4
Evolving insights in blood-based liquid biopsies for prostate cancer interrogation
R. Daniel Bonfil, Ghaith Al‐Eyd
Oncoscience (2023) Vol. 10, pp. 69-80
Open Access | Times Cited: 2
In vitro diagnostics in oncology in precision medicine
Donna M. Roscoe
Elsevier eBooks (2024), pp. 49-82
Closed Access
Fast-tracking drug development with biomarkers and companion diagnostics
Noreen McBrearty, Devika Bahal, Suso Platero
Journal of Cancer Metastasis and Treatment (2024)
Open Access
The Role of Liquid Biopsy as a Catalyst for Sustained Progress in Precision Oncology – Perspective of The Young Committee of The International Society of Liquid Biopsy
Erick Figueiredo Saldanha, Eleonora Nicolò, Konstantinos Venetis, et al.
The Journal of Liquid Biopsy (2024) Vol. 5, pp. 100156-100156
Closed Access
The Value of Perioperative Immunotherapy for Non-Small Cell Lung Cancer: A Pool- and Meta-Analysis
Yanmeng Wu, Lin Hu, Shuling Zhang, et al.
Technology in Cancer Research & Treatment (2024) Vol. 23
Open Access
Optimizing ctDNA: An Updated Review of a Promising Clinical Tool for the Management of Uveal Melanoma
Mar Varela, Sergi Villatoro, Daniel Lorenzo, et al.
Cancers (2024) Vol. 16, Iss. 17, pp. 3053-3053
Open Access
A Perspective: The Integration of ctDNA into Response Evaluation Criteria in Solid Tumours 1.1 for Phase II Immunotherapy Clinical Trials
Tülay Kuş, İrfan Çiçin
Immunotherapy (2024) Vol. 16, Iss. 5, pp. 319-329
Closed Access
Advancing Evidence Generation for Circulating Tumor DNA: Lessons Learned from A Multi-Assay Study of Baseline Circulating Tumor DNA Levels across Cancer Types and Stages
Brittany McKelvey, Hillary S. Andrews, Frederick L. Baehner, et al.
Diagnostics (2024) Vol. 14, Iss. 9, pp. 912-912
Open Access
Identifying key circulating tumor DNA parameters for predicting clinical outcomes in metastatic non-squamous non-small cell lung cancer after first-line chemoimmunotherapy
Haolun Ding, Min Yuan, Yaning Yang, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access
Application of ctDNA in Colorectal Cancer Detection
明月 王
Hans Journal of Biomedicine (2024) Vol. 14, Iss. 04, pp. 583-589
Closed Access
Liquid biopsy approaches to capture minimal residual disease and therapy response in patients with early stage cancers
Blair V. Landon, Jinny Huang, Ellie G. Evangelopoulou, et al.
International review of cell and molecular biology (2024)
Closed Access
Page 1

Scroll to top